Varonis Systems Securities Fraud Class Action Seeks Lead Plaintiffs

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Schall Law Firm launches securities fraud class action against Varonis Systems for allegedly making false statements about SaaS customer conversion and revenue growth during 2025.

Varonis Systems Securities Fraud Class Action Seeks Lead Plaintiffs

The Schall Law Firm is organizing a class action lawsuit against Varonis Systems, Inc. (NASDAQ: VRNS) on behalf of investors who purchased company securities during an eight-month period in 2025. The firm is seeking lead plaintiffs from among shareholders who acquired VRNS stock between February 4 and October 28, 2025, to represent the broader class of affected investors.

The lawsuit alleges that Varonis made materially false and misleading statements regarding its capacity to convert customers to its Software-as-a-Service (SaaS) platform. According to the legal claim, company management possessed knowledge that customer migration efforts were underperforming relative to public disclosures, thereby misrepresenting the trajectory of annual recurring revenue (ARR) growth. These assertions, if substantiated, would constitute violations of federal securities laws that protect investors from fraudulent corporate communications.

Investors who meet the eligibility criteria and wish to participate in the litigation or serve as lead plaintiffs have established deadlines for submitting their claims. The case represents an opportunity for affected shareholders to seek damages through the class action mechanism, which consolidates individual claims into a single proceeding.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 16

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON